Securities code: Shenzhen Neptunus Bioengineering Co.Ltd(000078) securities abbreviation: Shenzhen Neptunus Bioengineering Co.Ltd(000078) Announcement No.: 2022007 Shenzhen Neptunus Bioengineering Co.Ltd(000078)
Announcement on abnormal fluctuations in stock trading
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Abnormal fluctuations in stock trading
Shenzhen Neptunus Bioengineering Co.Ltd(000078) (hereinafter referred to as “the company” or “the company”) the stock price has deviated from the closing price by more than 20% for three consecutive trading days from March 2, 2022 to March 4, 2022. According to the relevant provisions of the trading rules of Shenzhen Stock Exchange, it belongs to the abnormal fluctuation of stock trading.
2、 Relevant information concerned and verified by the company
In view of the abnormal fluctuation of the company’s shares, after the company checked the relevant matters and sent a letter to the controlling shareholder and actual controller of the company for verification, the relevant information is explained as follows:
1. The information disclosed by the company in the early stage does not need to be corrected or supplemented.
2. The company has not found any unpublished material information that may or has had a great impact on the stock trading price of the company reported by public media recently.
3. Recently, the company’s production and operation and internal and external business environment have not changed significantly.
4. After verification, the company, controlling shareholders and actual controllers have no major matters that should be disclosed but not disclosed.
5. After verification, the controlling shareholder and actual controller of the company did not buy or sell the company’s shares during the abnormal fluctuation of the company’s stock trading.
6. The company disclosed the suggestive announcement on planning major events on cninfo.com on March 4, 2022. As of the disclosure date of this announcement, the company’s planning of major asset restructuring and mixed ownership reform are in the planning stage, with major uncertainties. In addition to the above matters, the company has no other major matters that should be disclosed but not disclosed.
3、 Description of material information that should be disclosed but not disclosed
After performing the verification procedures, the board of directors of the company confirmed that, except for the disclosed public information, the company currently has no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and other relevant provisions; The board of directors of the company has not been informed that the company has other information that should be disclosed in accordance with the relevant provisions of the Listing Rules of Shenzhen Stock Exchange and has a great impact on the trading price of the company’s shares; The information disclosed by the company in the early stage does not need to be corrected or supplemented.
4、 Risk tips
1. Through self-examination, the company does not violate the fair disclosure of information.
2. The company disclosed the suggestive announcement on planning major events on March 4, 2022. As of the disclosure date of this announcement, the company’s planning of major asset restructuring and mixed ownership reform are in the planning stage and there are major uncertainties. If there is relevant progress in the follow-up, the company will perform the obligation of information disclosure in strict accordance with relevant regulations, and supervise and prompt insiders to perform the obligation of confidentiality. Please invest rationally and pay attention to investment risks.
3. The company disclosed the annual performance forecast for 2021 on January 28, 2022. As of the disclosure date of this announcement, there is no situation that the performance forecast should be amended. The forecast data of 2021 annual performance forecast is the preliminary estimation result of the company’s financial department. The specific financial data shall be subject to the 2021 annual report disclosed by the company.
4. The company hereby reminds investors that China Securities News, securities times, Securities Daily, Shanghai Securities News and cninfo are the information disclosure media designated by the company. All information of the company shall be subject to the information published in the above designated media. Please invest rationally and pay attention to risks.
It is hereby announced.
Shenzhen Neptunus Bioengineering Co.Ltd(000078) board of directors
March 4, 2002
